Shopping Cart
- Remove All
- Your shopping cart is currently empty
Androgen receptor antagonist 4 (Compound AT2) exhibits anticancer activities by potently antagonizing AR transcriptional activity, inhibiting downstream AR target genes, and blocking DHT-induced nuclear translocation of AR. It is an antagonist of the androgen receptor (AR) with an IC50 of 0.15 μM [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | 2.033 € | 6-8 weeks | |
50 mg | 2.645 € | 6-8 weeks | |
100 mg | 3.344 € | 6-8 weeks |
Description | Androgen receptor antagonist 4 (Compound AT2) exhibits anticancer activities by potently antagonizing AR transcriptional activity, inhibiting downstream AR target genes, and blocking DHT-induced nuclear translocation of AR. It is an antagonist of the androgen receptor (AR) with an IC50 of 0.15 μM [1]. |
Molecular Weight | 331.84 |
Formula | C22H18ClN |
Cas No. | 354815-43-3 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.